Found: 9
Select item for more details and to access through your institution.
Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease?
- Published in:
- 2021
- By:
- Publication type:
- journal article
Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease Patients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3689, doi. 10.3390/jcm10163689
- By:
- Publication type:
- Article
Interleukin 6, osteoprotegerin, sRANKL and bone metabolism in inflammatory bowel diseases.
- Published in:
- Advances in Clinical & Experimental Medicine, 2018, v. 27, n. 4, p. 449, doi. 10.17219/acem/75675
- By:
- Publication type:
- Article
Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.615539
- By:
- Publication type:
- Article
Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against SARS-CoV-2.
- Published in:
- Polish Archives of Internal Medicine, 2021, v. 131, n. 3, p. 226, doi. 10.20452/pamw.15796
- By:
- Publication type:
- Article
Prevalence of osteoporosis and osteopenia in patients with inflammatory bowel diseases from Greater Poland Province.
- Published in:
- Polish Archives of Internal Medicine, 2018, v. 128, n. 7/8, p. 447, doi. 10.20452/pamw.4292
- By:
- Publication type:
- Article
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231151295
- By:
- Publication type:
- Article
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, v. 16, p. 1, doi. 10.1177/17562848231151295
- By:
- Publication type:
- Article
Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study).
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211036456
- By:
- Publication type:
- Article